| Company/Division name | Pfizer Inc. |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 450 |
| Year reshoring announced: | 2018 |
| Year reshoring implemented or to be implemented: | 2024 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 465 |
| City reshored to: | Portage |
| State(s) reshored to: | MI |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | sterile injectable medicines, semi-solid medicines |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Impact on domestic economy, Lead time/Time to market, Other, import replacement |
